Abstract
The proportion of ciprofloxacin-resistant Gram-negative bacteria isolated from the blood of children with cancer (not receiving prophylaxis) was 10% in a paediatric hospital (Genoa) where the use of quinolones was highly restricted, compared with 41% in a department of haematology (Rome) where leukaemic adults, who received fluoroquinolone prophylaxis, were also treated (p < 0.0001). Moreover, simultaneous resistance to ciprofloxacin and ceftazidime, amikacin or imipenem-cilastatin was 11% in Genoa compared with 37% in Rome (p < 0.001). Ciprofloxacin resistance was more frequent in children who shared an environment with adults who were receiving ciprofloxacin prophylaxis.
MeSH terms
-
Amikacin / pharmacology
-
Anti-Bacterial Agents / pharmacology*
-
Anti-Bacterial Agents / therapeutic use
-
Bacteremia / microbiology*
-
Bacteremia / prevention & control
-
Ceftazidime / pharmacology
-
Child
-
Ciprofloxacin / pharmacology
-
Drug Resistance, Multiple, Bacterial
-
Fluoroquinolones / pharmacology*
-
Fluoroquinolones / therapeutic use
-
Gram-Negative Bacteria / drug effects*
-
Gram-Negative Bacteria / isolation & purification
-
Gram-Negative Bacterial Infections / microbiology*
-
Gram-Negative Bacterial Infections / prevention & control
-
Hospitals, Pediatric
-
Humans
-
Imipenem / pharmacology
-
Italy
-
Neoplasms / blood
-
Neoplasms / complications*
-
Retrospective Studies
Substances
-
Anti-Bacterial Agents
-
Fluoroquinolones
-
Ciprofloxacin
-
Imipenem
-
Amikacin
-
Ceftazidime